Abstract: Hereby a microfluidic system for cell cultivation is presented in which human pluripotent stem cell-derived cardiomyocytes were cultivated under perfusion. Besides micro-perfusion this system is also capable to produce welldefined oxygen contents, apply defined forces and has excellent imaging characteristics. Cardiomyocytes attach to the surface, start spontaneous beating and stay functional for up to 14 days under perfusion. The cell motion was subsequently analysed using an adapted video analysis script to calculate beating rate, beating direction and contraction or relaxation speed.
Introduction
Cardiovascular diseases (CVDs) are among the main causes of death worldwide. Until now, efficient therapies for many heart diseases are still missing. One of the limitations in the development of therapies for CVDs is the lack of an adequate human model for drug testing, which could be used for screening of cardiac effect and toxicity. Currently, these tests are performed mostly by using mouse models, however there are several limitations including species-specific toxicity response, differences in pharmacokinetics and ethical issues. Additionally, different from human tissue composition (e.g. higher cardiomyocytes-to-fibroblasts ratio) and higher regenerative capacities of animal models call their use for predicting clinical relevance of the drug into question. Moreover, many CVDs develop through a long time span and are connected with the increasing of patients' age. Therefore, a suitable model should resemble human, adult heart tissue and be able to show clinical symptoms as observed in adult patients. These together with instantly rising costs of the developmental process of new drugs (approx. 1 billion $ per drug) lead to an increasing need for reliable human cardiac tissue models that would be capable for implementation into a high-throughput drug screening platform to study their cardiac effects and toxicity.
In recent years, we have witnessed an intensive development of in vitro patient-specific cardiac models. This was possible thanks to (1) generation of induced pluripotent stem cells (iPSCs) from somatic cells of the patient and (2) optimization of in vitro differentiation of iPSCs into cardiomyocytes (CMs) [1] . Currently, we are able to derive human chamber-specific CMs using robust and highly efficient protocols [2] [3] [4] . Although these cells are capable of spontaneous beating and show many physiological features of CMs, they remain immature. There are many features in which differences could be observed, including smaller cell size, different shape, different expression levels of ion channels as well as lower oxygen consumption levels and force development [5] [6] [7] [8] . This immature physiology of iPSCderived CMs (iPSC-CMs) leads to differences in pharmacological response to many drugs tested thus far (including tetrodoxin, nisoldipine or lidocaine) [9] . Importance of the maturation state of iPSC-CMs is even more crucial for modelling diseases that are known to develop with age such as dilated cardiomyopathy (DCM) or cardiac pathological hypertrophy. Establishing the adult phenotype in these cells would potentiate the progress in pharmacological studies in the field. To achieve mature cardiac tissue in vitro, more stimuli than biochemical signalling should be applied. This includes mechanical and electrical stimulation, control of oxygen levels and 3D cultures to ensure cell-to-cell and cell-to- extracellular matrix mechanical contact. Therefore, a first phase of microfluidic system implementation is pursued in this work. These systems offer a controllable environment for tissue maturation, including emulating of the heart vascular system, controlled oxygen environment together with mechanical and electrical stimulation. These microfluidic systems are also able to support 3D cell culture models [10, 11] .
Results

Microfluidic system development
One of the main benefits of the presented microfluidic system is the possibility to integrate microfluidic actuators. This allows creating completely closed and perfused microfluidic circuits and microvascular systems with small volumes in the range of several µL. The microfluidic system is produced with a layer-by-layer manufacturing technology of laser-cut polymer foils [12] . The mentioned fluidic actuators are pneumatically driven systems [13] . Therefore, a flexible membrane must be integrated into the microfluidic system, which is moveable with pressures below 100 kPa. A commercially available silicone foil (SILPURAN® FILM, Wacker Chemie AG) with a thickness of 200 microns and high gas permeability is perfectly suited for this application. In Figure a an exploded view of the microfluidic system with mounted reservoirs on top, the pneumatic part, the elastomeric membrane in the middle and the fluidic part at the bottom is shown. The complete system is mounted in a chip holder with two connection elements which include the pneumatic fittings. Figure b shows the developed fluidic layout. It features a micro pump for fluid actuation, in-and outlets for medium exchange, a cell culture chamber, a valve to operate the system either as flow through or circulation device and an additional helical shaped oxygenator element to ensure sufficient oxygen supply for the cells. The fluid flow within the micro channels was observed using a micro-ParticleImage-Velocimetry setting [14] at the marked spots in Figure  b [15] . The Oxygen content can be measured and controlled by means of fluorescence decay detection [16] combined with a process gas-mixing unit [17] . This setup can be used to establish well-defined oxygen milieus in cell cultures e.g. for hypoxia assays. The cell culture chamber is either operated as open vessel or closed with a sealing tape.
Cell culture results
In all presented experiments, human iPSC-CMs were used. The generation and pluripotency characterisation of the iPSC line used in this study, which was derived from bone marrow cells of a healthy control, has been described previously [18] . Human iPSCs were subjected to differentiation procedure according to established protocols [19] . Briefly, iPSCs were cultured in 12-well plates to reach 100% confluence. At this time (day 0), medium was changed to RPMI1640 with Glutamax and Hepes (ThermoFisher Scientific, Waltham, USA), and 1x B27 w/o insulin (ThermoFisher Scientific) (Cardiac Differentiation Medium 1, CDM1) supplemented with ROCK-inhibitor (9 µM CHIR99021, MerckMilipore,). After 24 h, 2 ml of fresh CDM1 was added. At day 3, 1 ml of medium was subtracted and fresh CDM1 with 10 µM IWP2 (MerckMilipore,) was added. At day 5 the medium was changed again to fresh CDM1. At day 7, the medium was changed to RPMI1640 with Glutamax and Hepes, and 1x B27 with insulin (ThermoFisher Scientific) (Cardiac Differentiation Medium 2, CDM2). Afterwards, the medium was changed every 3 days. Between day 14 and day 18, cells were selected using lactate as described by Thoyama et al [20] .
In this application, we used over 95% pure, selected CMs at day 20-30 to directly define the influence of the microfluidic system on the iPSC-CM culture properties. These cells were afterwards transferred to the firstly opened cell culture segment of the micro device. The chip surface was coated with 4 mg/mL concentrated Geltrex® (Thermo Fischer Scientific) and incubated for 3 h at 37 °C. CMs were seeded with a concentration of 1.5*10 6 cells / mL directly after coating and incubated static for 12 h (Figure top) . To maintain sufficient nutrient supply until the cells completely attached to the surface, a slow pumping frequency of 0.2 Hz was chosen (pumping pressure: ± 50 kPa). After 3 days of culture, CMs completely attached to the surface and started spontaneous beating. At this stage, the pumping frequency was increased to 0.4 Hz and the culture chamber was sealed with tape, so that oxygen input was completely performed by the oxygenator. The total cell culture medium volume (est. 200 µL) was exchanged every day by closing the valve between in-and outlet for several minutes. After 14 days of culture ( Figure bottom ) the cells were removed from the microfluidic device and fixed for further staining processes (not part of this work). As positive control the same cell population and density was cultivated in a dish to compare their beating and vitality markers with the cells in the microfluidic system.
Video data analysis
Of particular interest is the natural beating motion of the CMs as it is connected to the maturation state of the cells, and thus their reaction to certain substances and other stimuli. The beating motion can be divided into a contraction phase and a relaxation phase and is periodic with a specific beating rate. The cell motion is observed via standard phase contrast microscopy at a frame rate of 30 fps. Captured video sequences of 20-seconds duration were processed afterwards with a MATLAB algorithm developed by a group at the University of California [21] . Each frame is segmented into so-called macro blocks (16 Px size), for which the displacement vector is calculated using a cross-correlation algorithm. Later on, the motion vectors are exported to an inhouse developed vector analysis software to extract information like the beating rate, the contraction and relaxation speed or the contraction direction (alignment). In Figure the relaxation vectors of a beating area inside the cell culture chamber are shown with red arrows. The motion vector magnitudes and beating rates are comparable to static culture. Further data processing, especially regarding the orientation of the motion vectors should show whether the flow leads to a stronger alignment of the contraction and relaxation movement, as it is the case in the human heart and therefore is suited to produce more in-vivo like models. 
Conclusion and outlook
Human iPSC-CMs were successfully cultivated for up to 14 days under perfusion in a completely closed microfluidic system with a total volume of 200 µL. The cells started beating after several days and behaved comparably to the static cultivated positive control as the video analysis data proves. In the next steps cell alignment should be checked, because perfusion may improve the direction of the beating motion. Therefore, the in-house developed vector analysis tool can be used to calculate the beating angles of the CMs.
To improve the maturation state of the cells, further stimuli like oxygen restriction as well as mechanical and electrical stimulation should be implemented in the microfluidic system. Moreover, 3D cell culture models instead of adherent CM cultivation should be used to include CM-fibroblast interaction.
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